Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and distributes food supplements. In addition, it distributes and trades diagnostic products; and develops OLIN digital platform, an integrated digital platform for ordering, inventory, billing, and sales operations. Further, the company provides logistics services and primary care products for acute diseases and specialty care products for serious and chronic diseases. Pharmaniaga Berhad was founded in 1994 and is based in Shah Alam, Malaysia.
Research context
Pharmaniaga Bhd appears in PyInvesting’s Kuala Lumpur Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- MYR
- Sector
- Healthcare
- Industry
- Medical Distribution
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Pharmaniaga Bhd is currently in a long term downtrend where the price is trading 78.3% below its 200 day moving average.
From a valuation standpoint, the stock is 95.3% cheaper than other stocks from the Other sector with a price to sales ratio of 0.3.
Pharmaniaga Bhd's total revenue sank by 12.8% to $625M since the same quarter in the previous year.
Its net income has increased by 199.8% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 647.5% to $-86M since the same quarter in the previous year.
Based on the above factors, Pharmaniaga Bhd gets an overall score of 2/5.